SELLAS Life Sciences announces pricing of $15 million public offering
SELLAS Life Sciences announced pricing of an underwritten public offering of (i) 26,367,200 shares of common stock together with common stock warrants to purchase 26,367,200 shares of common stock and (ii) 73,632,800 pre-funded warrants exercisable for one share of common stock. June 14, 2019